Medical Solutions expands genomics offerings with Autogen buy
This article was originally published in Clinica
Executive Summary
In a move to expand its molecular diagnostics business, UK Medical Solutions has conditionally agreed to acquire Autogen Bioclear in an all-cash deal worth up to £6m ($12m). Calne, Wiltshire-based Autogen distributes diagnostic kits, antibodies, DNA clones and other products for genetic testing to the academic and charitably-funded research sectors. The company, which has nine employees, posted a turnover of £2.7m (+10%) for fiscal 2007, while pre-tax profits were up 47% at £823,000. Medical Solutions, based in Nottingham, said the acquisition would present cross-selling opportunities and cost savings, among other benefits.
You may also be interested in...
Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
Hair Supplement Linked To Cases Of Severe Hepatitis In France
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
AZ Will Sideline ‘Lucky Mistake’ Data To Secure COVID-19 Vaccine Approval
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: